These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32302443)

  • 21. Prognostic value of tumor-infiltrating lymphocytes and PD-L1 expression in esophageal squamous cell carcinoma.
    Hu J; Toyozumi T; Murakami K; Endo S; Matsumoto Y; Otsuka R; Shiraishi T; Iida S; Morishita H; Makiyama T; Nishioka Y; Uesato M; Hayano K; Nakano A; Matsubara H
    Cancer Med; 2024 Sep; 13(17):e70179. PubMed ID: 39264227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-[3-¹⁸F]-α-methyltyrosine uptake by lymph node metastasis is a predictor of complete response to CRT in esophageal cancer.
    Sohda M; Miyazaki T; Honjyo H; Hara K; Ozawa D; Suzuki S; Tanaka N; Sano A; Sakai M; Yokobori T; Nakajima M; Fukuchi M; Kato H; Higuchi T; Tsushima Y; Kuwano H
    Anticancer Res; 2014 Dec; 34(12):7473-7. PubMed ID: 25503190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor SUVs on 18F-FDG PET/CT and Aggressive Pathological Features in Esophageal Squamous Cell Carcinoma.
    Lim CH; Park YJ; Shin M; Cho YS; Choi JY; Lee KH; Hyun SH
    Clin Nucl Med; 2020 Mar; 45(3):e128-e133. PubMed ID: 31977480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of increased p53 expression in the decrease of mitochondrial DNA copy number and increase of SUV
    Lin CS; Huang YY; Pan SC; Cheng CT; Liu CC; Shih CH; Ho HL; Yeh YC; Chou TY; Lee MY; Wei YH
    Mitochondrion; 2019 Jul; 47():54-63. PubMed ID: 31071450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complementary roles of tumour specific PET tracer ¹⁸F-FAMT to ¹⁸F-FDG PET/CT for the assessment of bone metastasis.
    Morita M; Higuchi T; Achmad A; Tokue A; Arisaka Y; Tsushima Y
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1672-81. PubMed ID: 24006150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FAMT-PET is useful for the diagnosis of lymph node metastasis in operable esophageal squamous cell carcinoma.
    Sohda M; Kato H; Suzuki S; Tanaka N; Sano A; Sakai M; Inose T; Nakajima M; Miyazaki T; Fukuchi M; Oriuchi N; Endo K; Kuwano H
    Ann Surg Oncol; 2010 Dec; 17(12):3181-6. PubMed ID: 20614194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular biological correlation of fluorine-18 fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
    Hirose Y; Kaida H; Kawahara A; Matono S; Tanaka T; Kurata S; Kage M; Ishibashi M; Abe T
    Nucl Med Commun; 2016 Oct; 37(10):1053-61. PubMed ID: 27218430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of ¹⁸F-fluorodeoxyglucose positron emission tomography in superficial esophageal squamous cell carcinoma.
    Kita Y; Okumura H; Uchikado Y; Sasaki K; Omoto I; Matsumoto M; Setoyama T; Tanoue K; Mori S; Owaki T; Ishigami S; Ueno S; Kajiya Y; Natsugoe S
    Ann Surg Oncol; 2013 May; 20(5):1646-52. PubMed ID: 23238695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinoma.
    Guo W; Zhang F; Shao F; Wang P; Li Z; Yang X; He Z; Shi S; Gao Y; He J
    Hum Pathol; 2019 Feb; 84():291-298. PubMed ID: 30296523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population.
    Rong L; Liu Y; Hui Z; Zhao Z; Zhang Y; Wang B; Yuan Y; Li W; Guo L; Ying J; Song Y; Wang L; Zhou Z; Xue L; Lu N
    Diagn Pathol; 2019 Jan; 14(1):6. PubMed ID: 30684971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of metabolic tumor volume of pretreatment
    Kumasaka S; Nakajima T; Arisaka Y; Tokue A; Achmad A; Fukushima Y; Shimizu K; Kaira K; Higuchi T; Tsushima Y
    BMC Med Imaging; 2018 Nov; 18(1):46. PubMed ID: 30477476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of characteristics of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET during staging of esophageal squamous cell carcinoma.
    Ma C; Li D; Yin Y; Cao J
    Nucl Med Commun; 2015 Dec; 36(12):1181-6. PubMed ID: 26367213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
    Furukawa T; Hamai Y; Hihara J; Emi M; Yamakita I; Ibuki Y; Okada M
    Ann Surg Oncol; 2016 Nov; 23(12):4086-4092. PubMed ID: 27352201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy.
    Hamai Y; Emi M; Ibuki Y; Murakami Y; Nishibuchi I; Nagata Y; Furukawa T; Kurokawa T; Ohsawa M; Yoshikawa T; Okada M
    Ann Surg Oncol; 2020 Oct; 27(11):4422-4430. PubMed ID: 32405978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
    Yudistiro R; Arisaka Y; Tokue A; Nakajima T
    BMC Med Imaging; 2016 Jan; 16():1. PubMed ID: 26746426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between the expression of PD-1/PD-L1 and
    Chen R; Zhou X; Liu J; Huang G
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):848-854. PubMed ID: 30627815
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Mitchell KG; Amini B; Wang Y; Carter BW; Godoy MCB; Parra ER; Behrens C; Villalobos P; Reuben A; Lee JJ; Weissferdt A; Moran CA; Fujimoto J; Sepesi B; Walsh GL; Vaporciyan AA; Hofstetter WL; William WN; Gibbons DL; Wang J; Hwu P; Swisher SG; Piwnica-Worms D; Kadara H; Wistuba II; Heymach JV; Peng W; Cascone T
    Cancer Immunol Immunother; 2020 Aug; 69(8):1519-1534. PubMed ID: 32300858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma.
    Hatogai K; Fujii S; Kitano S; Kojima T; Daiko H; Yoshino T; Ohtsu A; Takiguchi Y; Doi T; Ochiai A
    Br J Cancer; 2020 Feb; 122(3):413-420. PubMed ID: 31761900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
    Hiyoshi Y; Watanabe M; Imamura Y; Nagai Y; Baba Y; Yoshida N; Toyama E; Hayashi N; Baba H
    Oncology; 2009; 76(4):286-92. PubMed ID: 19262068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative Correlation Between
    Wu L; Liu J; Wang S; Bai M; Wu M; Gao Z; Li J; Yu J; Liu J; Meng X
    Front Endocrinol (Lausanne); 2022; 13():913631. PubMed ID: 35846323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.